Fast-Track Early Proof of Mechanism with Challenge Agents

In early-phase clinical research, chemical challenge agents offer a fast, reliable way to demonstrate proof of mechanism - showing whether a drug works as intended.

This webinar will explain how SGS applies these models to accelerate development by safely generating early efficacy data that support stronger funding and go/no-go decisions.

Learn how chemical challenge agents work, when to apply them and how SGS’ proven approach helps pharma and biotech teams gain meaningful early efficacy insights safely and efficiently.

Agenda

• Introduction to chemical challenge agents in early development
• Overview of commonly used agents and their applications
• Case examples from SGS’ clinical experience
• Live Q&A

Who should attend?

The webinar is designed for small to mid-sized biotech companies in early clinical development, including CSOs, CMOs, clinical program leads, scientific directors and decision-makers seeking faster, data-driven proof of mechanism to guide development strategy.

Register now

This event takes place on December 4, 2025, at 03:00 PM CET.